Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-10-036427
Filing Date
2010-07-02
Accepted
2010-07-02 16:12:24
Documents
5
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 v189710_10k.htm 10-K 894131
2 v189710_ex31-1.htm EX-31.1 16296
3 v189710_ex31-2.htm EX-31.2 16546
4 v189710_ex32-1.htm EX-32.1 7324
5 v189710_ex32-2.htm EX-32.2 7732
  Complete submission text file 0001144204-10-036427.txt   943650
Mailing Address 4020 ST-AMBROISE SUITE 497 MONTREAL A8 H4C 2C7
Business Address 4020 ST-AMBROISE SUITE 497 MONTREAL A8 H4C 2C7 438-380-9324 X222
Neuro Biotech Corp (Filer) CIK: 0000894561 (see all company filings)

EIN.: 870485310 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 033-55254-42 | Film No.: 10936320
SIC: 6770 Blank Checks